In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 04, 2021
Source ID
10.1021/acsinfecdis.1c00190

Entities

People

  • Anastasia Levitin
  • Aram Derbedrossian
  • Chi-lee C. Ho
  • Chiu-yen Kao
  • Christopher K Cote
  • Christopher P. Klimko
  • David P. Fetterer
  • David W. C. Beasley
  • Emiene Amali-adekwu
  • Gloria Bartolo
  • Jennifer E. Peel
  • Jennifer K. Tran
  • Jennifer L. Shoe
  • Joel West
  • Johnny W. Peterson
  • Kenneth A. Bradley
  • Leeor Zilbermintz
  • Luisa W. Cheng
  • Lynda L. Miller
  • Marina Chugunova
  • Mikhail Martchenko
  • Ryan Mccomb
  • Saleem Alameh
  • Samandra T. Demons
  • Satheesh K. Sivasubramani
  • Stella Hartmann
  • Stephanie A. Halasahoris
  • William S. Lawrence

Organizations

  • Claremont Graduate University
  • Claremont McKenna College
  • Comprehensive Cancer Center, City of Hope
  • Defense Threat Reduction Agency
  • Keck Graduate Institute
  • National Institute of Allergy and Infectious Diseases
  • United States Army Medical Research Institute of Infectious Diseases
  • University of California, Los Angeles
  • University of Texas Medical Branch